Stay updated with breaking news from Invalidation Decision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xuelan Yue of Liu, Shen & Associates reviews the history of China’s Patent Law as it pertains to inventions developed in China and confidentiality examinations, and discusses best practices for filing patent applications
The China National Intellectual Property Administration (CNIPA) circulated a draft amendment to the PRC Trademark Law (TML Draft Amendment) for public comment on January 13, 2023. The...
The patent Prioritized Examination (PE) program in China is a main Way to accelerate the patent prosecution, besides the well- known Patent…
Polymorphism of a pharmaceutical compound refers to its state of existing in different solid forms that is caused by the fact that the molecules of the compound, though being of the...
China: CNIPA and courts open door to post-filing supplementary data Li Wu of AnJie Law Firm explains how the administrative and judicial sectors are slowly embracing a more favourable stance towards the acceptance of post-filing supplementary data Sponsored by February 23 2021 China had long been criticised for adopting much stricter criteria for post-filing supplementary data in the pharmaceutical field than other major patent systems. The issue was even discussed as one of the main topics of the US-China trade talks and was listed ...